{"pmid":32451257,"pmcid":"PMC7211612","title":"Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019.","text":["Importance of timely management of patients in reducing fatality rate of coronavirus disease 2019.","The outbreak of coronavirus disease 2019 (COVID-19) characterized with pneumonia, firstly occurred in Wuhan city, China, in December 2019 has so far spread in over 200 countries and territories in the world. One of the important goals in facing outbreaks of COVID-19 is to reduce the case fatality rate. We reported here that the fatality rate of COVID-19 in other provinces of mainland China was 0.82% (121/14,708), significantly lower than 6.62% (4512/68,128) in Hubei province (p<0.0001). The main reason for the lower fatality rate was likely due to the timely management of the patients in other provinces, highlighting the importance of timely management of patients in reducing the fatality rate of COVID-19.","J Infect Public Health","Peng, Yuzhu","Xu, Biyun","Sun, Beicheng","Han, Guangshu","Zhou, Yi-Hua","32451257"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) characterized with pneumonia, firstly occurred in Wuhan city, China, in December 2019 has so far spread in over 200 countries and territories in the world. One of the important goals in facing outbreaks of COVID-19 is to reduce the case fatality rate. We reported here that the fatality rate of COVID-19 in other provinces of mainland China was 0.82% (121/14,708), significantly lower than 6.62% (4512/68,128) in Hubei province (p<0.0001). The main reason for the lower fatality rate was likely due to the timely management of the patients in other provinces, highlighting the importance of timely management of patients in reducing the fatality rate of COVID-19."],"journal":"J Infect Public Health","authors":["Peng, Yuzhu","Xu, Biyun","Sun, Beicheng","Han, Guangshu","Zhou, Yi-Hua"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451257","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.jiph.2020.04.015","keywords":["coronavirus disease 2019 (covid-19)","fatality rate","timely management"],"locations":["Wuhan","China","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667983494509232128,"score":9.490897,"similar":[{"pmid":32175421,"pmcid":"PMC7049028","title":"Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis.","text":["Early estimation of the case fatality rate of COVID-19 in mainland China: a data-driven analysis.","Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date. Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster. Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan. Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV).","Ann Transl Med","Yang, Shu","Cao, Peihua","Du, Peipei","Wu, Ziting","Zhuang, Zian","Yang, Lin","Yu, Xuan","Zhou, Qi","Feng, Xixi","Wang, Xiaohui","Li, Weiguo","Liu, Enmei","Chen, Ju","Chen, Yaolong","He, Daihai","32175421"],"abstract":["Background: An ongoing outbreak of pneumonia caused by a novel coronavirus [severe acute respiratory syndrome coronavirus (SARS-CoV)-2], named COVID-19, hit a major city of China, Wuhan in December 2019 and subsequently spread to other provinces/regions of China and overseas. Several studies have been done to estimate the basic reproduction number in the early phase of this outbreak, yet there are no reliable estimates of case fatality rate (CFR) for COVID-19 to date. Methods: In this study, we used a purely data-driven statistical method to estimate the CFR in the early phase of the COVID-19 outbreak. Daily numbers of laboratory-confirmed COVID-19 cases and deaths were collected from January 10 to February 3, 2020 and divided into three clusters: Wuhan city, other cities of Hubei province, and other provinces of mainland China. Simple linear regression model was applied to estimate the CFR from each cluster. Results: We estimated that CFR during the first weeks of the epidemic ranges from 0.15% (95% CI: 0.12-0.18%) in mainland China excluding Hubei through 1.41% (95% CI: 1.38-1.45%) in Hubei province excluding the city of Wuhan to 5.25% (95% CI: 4.98-5.51%) in Wuhan. Conclusions: Our early estimates suggest that the CFR of COVID-19 is lower than the previous coronavirus epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV)."],"journal":"Ann Transl Med","authors":["Yang, Shu","Cao, Peihua","Du, Peipei","Wu, Ziting","Zhuang, Zian","Yang, Lin","Yu, Xuan","Zhou, Qi","Feng, Xixi","Wang, Xiaohui","Li, Weiguo","Liu, Enmei","Chen, Ju","Chen, Yaolong","He, Daihai"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32175421","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.21037/atm.2020.02.66","keywords":["2019 novel coronavirus","covid-19","case fatality rate (cfr)","severe acute respiratory syndrome coronavirus-2 (sars-cov-2)"],"locations":["China","Wuhan","China","Wuhan","Hubei","China","China","Hubei","Hubei","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138492585902081,"score":207.68958},{"pmid":32162702,"title":"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","text":["COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","The aim of this study was to analyze the clinical data, discharge rate, and fatality rate of COVID-19 patients for clinical help. The clinical data of COVID-19 patients from December 2019 to February 2020 were retrieved from four databases. We statistically analyzed the clinical symptoms and laboratory results of COVID-19 patients and explained the discharge rate and fatality rate with a single-arm meta-analysis. The available data of 1994 patients in 10 literatures were included in our study. The main clinical symptoms of COVID-19 patients were fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%). Minor symptoms include headache or dizziness (12.1%), diarrhea (4.8%), nausea and vomiting (3.9%). The results of the laboratory showed that the lymphocytopenia (64.5%), increase of C-reactive protein (44.3%), increase of lactic dehydrogenase (28.3%), and leukocytopenia (29.4%) were more common. The results of single-arm meta-analysis showed that the male took a larger percentage in the gender distribution of COVID-19 patients 60% (95% CI [0.54, 0.65]), the discharge rate of COVID-19 patients was 52% (95% CI [0.34,0.70]), and the fatality rate was 5% (95% CI [0.01,0.11]).","J Med Virol","Li, Long-Quan","Huang, Tian","Wang, Yong-Qing","Wang, Zheng-Ping","Liang, Yuan","Huang, Tao-Bi","Zhang, Hui-Yun","Sun, Weiming","Wang, Yuping","32162702"],"abstract":["The aim of this study was to analyze the clinical data, discharge rate, and fatality rate of COVID-19 patients for clinical help. The clinical data of COVID-19 patients from December 2019 to February 2020 were retrieved from four databases. We statistically analyzed the clinical symptoms and laboratory results of COVID-19 patients and explained the discharge rate and fatality rate with a single-arm meta-analysis. The available data of 1994 patients in 10 literatures were included in our study. The main clinical symptoms of COVID-19 patients were fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%). Minor symptoms include headache or dizziness (12.1%), diarrhea (4.8%), nausea and vomiting (3.9%). The results of the laboratory showed that the lymphocytopenia (64.5%), increase of C-reactive protein (44.3%), increase of lactic dehydrogenase (28.3%), and leukocytopenia (29.4%) were more common. The results of single-arm meta-analysis showed that the male took a larger percentage in the gender distribution of COVID-19 patients 60% (95% CI [0.54, 0.65]), the discharge rate of COVID-19 patients was 52% (95% CI [0.34,0.70]), and the fatality rate was 5% (95% CI [0.01,0.11])."],"journal":"J Med Virol","authors":["Li, Long-Quan","Huang, Tian","Wang, Yong-Qing","Wang, Zheng-Ping","Liang, Yuan","Huang, Tao-Bi","Zhang, Hui-Yun","Sun, Weiming","Wang, Yuping"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32162702","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.1002/jmv.25757","keywords":["2019-ncov","covid-19","clinical characteristics","discharge rate","fatality rate","meta-analysis"],"locations":["myalgia","fatigue"],"topics":["Mechanism"],"weight":1,"_version_":1666138490652327936,"score":195.05527},{"pmid":32168463,"title":"Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.","text":["Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.","We estimated the case-fatality risk for 2019 novel coronavirus disease cases in China (3.5%); China, excluding Hubei Province (0.8%); 82 countries, territories, and areas (4.2%); and on a cruise ship (0.6%). Lower estimates might be closest to the true value, but a broad range of 0.25%-3.0% probably should be considered.","Emerg Infect Dis","Wilson, Nick","Kvalsvig, Amanda","Barnard, Lucy Telfar","Baker, Michael G","32168463"],"abstract":["We estimated the case-fatality risk for 2019 novel coronavirus disease cases in China (3.5%); China, excluding Hubei Province (0.8%); 82 countries, territories, and areas (4.2%); and on a cruise ship (0.6%). Lower estimates might be closest to the true value, but a broad range of 0.25%-3.0% probably should be considered."],"journal":"Emerg Infect Dis","authors":["Wilson, Nick","Kvalsvig, Amanda","Barnard, Lucy Telfar","Baker, Michael G"],"date":"2020-03-14T11:00:00Z","year":2020,"_id":"32168463","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.3201/eid2606.200320","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","case-fatality risk","coronaviruses","pandemic","respiratory diseases","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["China","China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138492624699392,"score":179.96562},{"pmid":32334207,"pmcid":"PMC7139242","title":"Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm.","text":["Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm.","The global COVID-19 outbreak is worrisome both for its high rate of spread, and the high case fatality rate reported by early studies and now in Italy. We report a new methodology, the Patient Information Based Algorithm (PIBA), for estimating the death rate of a disease in real-time using publicly available data collected during an outbreak. PIBA estimated the death rate based on data of the patients in Wuhan and then in other cities throughout China. The estimated days from hospital admission to death was 13 (standard deviation (SD), 6days). The death rates based on PIBA were used to predict the daily numbers of deaths since the week of February 25, 2020, in China overall, Hubei province, Wuhan city, and the rest of the country except Hubei province. The death rate of COVID-19 ranges from 0.75% to 3% and may decrease in the future. The results showed that the real death numbers had fallen into the predicted ranges. In addition, using the preliminary data from China, the PIBA method was successfully used to estimate the death rate and predict the death numbers of the Korean population. In conclusion, PIBA can be used to efficiently estimate the death rate of a new infectious disease in real-time and to predict future deaths. The spread of 2019-nCoV and its case fatality rate may vary in regions with different climates and temperatures from Hubei and Wuhan. PIBA model can be built based on known information of early patients in different countries.","Sci Total Environ","Wang, Lishi","Li, Jing","Guo, Sumin","Xie, Ning","Yao, Lan","Cao, Yanhong","Day, Sara W","Howard, Scott C","Graff, J Carolyn","Gu, Tianshu","Ji, Jiafu","Gu, Weikuan","Sun, Dianjun","32334207"],"abstract":["The global COVID-19 outbreak is worrisome both for its high rate of spread, and the high case fatality rate reported by early studies and now in Italy. We report a new methodology, the Patient Information Based Algorithm (PIBA), for estimating the death rate of a disease in real-time using publicly available data collected during an outbreak. PIBA estimated the death rate based on data of the patients in Wuhan and then in other cities throughout China. The estimated days from hospital admission to death was 13 (standard deviation (SD), 6days). The death rates based on PIBA were used to predict the daily numbers of deaths since the week of February 25, 2020, in China overall, Hubei province, Wuhan city, and the rest of the country except Hubei province. The death rate of COVID-19 ranges from 0.75% to 3% and may decrease in the future. The results showed that the real death numbers had fallen into the predicted ranges. In addition, using the preliminary data from China, the PIBA method was successfully used to estimate the death rate and predict the death numbers of the Korean population. In conclusion, PIBA can be used to efficiently estimate the death rate of a new infectious disease in real-time and to predict future deaths. The spread of 2019-nCoV and its case fatality rate may vary in regions with different climates and temperatures from Hubei and Wuhan. PIBA model can be built based on known information of early patients in different countries."],"journal":"Sci Total Environ","authors":["Wang, Lishi","Li, Jing","Guo, Sumin","Xie, Ning","Yao, Lan","Cao, Yanhong","Day, Sara W","Howard, Scott C","Graff, J Carolyn","Gu, Tianshu","Ji, Jiafu","Gu, Weikuan","Sun, Dianjun"],"date":"2020-04-26T11:00:00Z","year":2020,"_id":"32334207","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.scitotenv.2020.138394","keywords":["covid-19","coronavirus","death rate","inpatient","normal distribution","prediction"],"locations":["Italy","Wuhan","China","China","Hubei","Wuhan","Hubei","China","Korean","Hubei","Wuhan"],"countries":["Italy","China","Korea, Republic of"],"countries_codes":["ITA|Italy","CHN|China","KOR|Korea, Republic of"],"topics":["Epidemic Forecasting"],"weight":1,"_version_":1666138493987848193,"score":171.83612},{"pmid":32175637,"title":"Clinical features of deaths in the novel coronavirus epidemic in China.","text":["Clinical features of deaths in the novel coronavirus epidemic in China.","In response to the recent novel coronavirus outbreak originating in Wuhan, Hubei province, China, observations concerning novel coronavirus mortality are of urgent public health importance. The present work presents the first review of the fatal novel coronavirus cases in China. Clinical data of fatal cases published by the Chinese Government were studied. As of 2 February 2020, the clinical data of 46 fatal cases were identified. The case fatality rate was significantly higher in Hubei province than the rest of China. While 67% of all deceased patients were male, gender was unlikely to be associated with mortality. Diabetes was likely to be associated with mortality. There is, however, not yet sufficient evidence to support the association between hypertension and mortality as similar prevalence of hypertension was also observed in the Hubei population.","Rev Med Virol","Leung, Char","32175637"],"abstract":["In response to the recent novel coronavirus outbreak originating in Wuhan, Hubei province, China, observations concerning novel coronavirus mortality are of urgent public health importance. The present work presents the first review of the fatal novel coronavirus cases in China. Clinical data of fatal cases published by the Chinese Government were studied. As of 2 February 2020, the clinical data of 46 fatal cases were identified. The case fatality rate was significantly higher in Hubei province than the rest of China. While 67% of all deceased patients were male, gender was unlikely to be associated with mortality. Diabetes was likely to be associated with mortality. There is, however, not yet sufficient evidence to support the association between hypertension and mortality as similar prevalence of hypertension was also observed in the Hubei population."],"journal":"Rev Med Virol","authors":["Leung, Char"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32175637","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.1002/rmv.2103","keywords":["wuhan pneumonia","mortality","novel coronavirus"],"locations":["Wuhan","Hubei","China","China","Hubei","China","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1666138490595704832,"score":170.97269}]}